tfppTC ^ o o 3 o O f^ P-1 NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704 606-331-2838 513-381-2838 FAX: 513-381-6613 DAYTON.

TSCA Document Processing Center Attn: Section 8(e)/FYI M2.Z6 - 373V August 10,2006 Page 4 of 10 Attachment 1 July 19, 2006 "Note for settling parties" from the Science Panel (1 page) Note for settling parties We have prepared some outline protocols for several interlinked research components addressing the potential health effects of exposure to C8 around the Washington Works plant.

r P-1 HK' - O cZo 7 - 7 //- M Jjb' 377y DuPont Haskell Laboratory for Health and Environmental Sciences Elkton Road, P.O.

EOS-0210 Interim Report #18 Northern Alabama Potable Witter Systems, December 2005 Interim Report #18: Analysis of Water Samples from Northern Alabama Potable Water Systems, December 2005 Study Title A nalysis of Perfluo robutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), an d Perfluorooctanesulfonate (PFOS) in Wate r , So il, S edim ent, Fis h , Clam s, V eg etatio n , Sm all Mam m al Liver an d Sm all Mam m al S erum Using LC/MS/MS FOR THE 3M DECATUR MONITORING PROGRAM Data Requirement EPA TSCA Good Laboratory Practice Standards 40 CFR 792 Author M ichelle D.

Diabetes Care Publish Ahead of Print, published online December 29, 2008 Perjluoroalkyl chemicals, glucose homeostasis and metabolic syndrome Association Among Serum Perfluoroalkyl Chemicals, Glucose Homeostasis and Metabolic Syndrome in Adolescents and Adults Running title: PeruofGplkyl chemicals, glucose homeostasis and metabolic syndrome Chien-Yu Lin1-2'3, MD, MPH; pau-Chung Chen2, MD, PhD; Yu-Chuan Lin2' 4, MD; Lian-Yu Lin, MD, PhD5 1, Department of Internal iMedicine o f Nephrology, En Chu Kong Hospital, Taipei County, Taiwan 2, Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan 3, School o f Medicine, Fu Jen Catholic University, Taipei County, Taiwan 4, Department of Pediatrics, Taipei City H ospita*>Zhongxiao Branch, Taipei Taiwan 5, Department of Internal Medicine o f Cardiology, National Taiwan University Hospital, Taipei, Taiwan Corresponding author: Lian-Yu Lin E-mail: hspenosf5tvahoo.com.tw Submitted 3 October 2008 and accepted 17 December 2008.

SEVERN TRENT LABORATORIES ANALYTICAL REPORT JOB NUMBER: 245986 Prepared For: Weston Solutions, Inc. 1400 Weston Way Building 5-2 West Chester, PA 19380-1499 Project: Confidential Decatur - FC Investigation Attention: Jai Kesari Date: 05/05/2006 Signature Name: Richard C.

-/} && -- iZl&O Ce: R.

35pp. 3M Katherine E.

ee----e--e-- e ------------------ AR236-150 STUDYTITLE ExtractionoYfoPloktafosrsAinuamlyPseirsflUusoironogcHiaPnLeCs-uEllfoencartoesfprroamy/EMgagssMeSmpbercatrnoem,etArlybumen, and DRAETQAUIREMENTS Analytical Method Requirements STUDY DIRECTOR Sean Gallagher STUDYCOMPLETEDON : September 06, 2001 SE EERFORMINGLABORATORY/TESTING FACILITY Centre Analy3t0i4ca8lRLeasbeoarartcohriDersi,veInc.

NORTHERN KENTUCKY OFFICE SUITE 340 1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704 606-331 -2838 513-381-2838 FAX: 513-381-6613 DAYTON, OHIO OFFICE SUITE 900 110 NORTH MAIN STREET DAYTON, OHIO 45402-1 786 937-228-2838 FAX: 937-228-2816 ROBERTA.

: 3M Specialty Materials. .

AR226-2100 .

AR226-2187 EXPOSURE EVALUATION FOR NEW PROCESS AT FAYETTEVILLE SITE Prepared by DuPont Engineering Technology Debbie Mulrooney Cathie Barton August 20,2001 Revised February 20, 2002 EDD0068699 TABLE OF CONTENTS i Executive Summary 1.

AR226-2266 Robert F Pinchot 03/27/2002 12:49 PM To: cc: Subject: Steven L Grise/AE/DuPontQDuPont, Debbie J Mulrooney/AE/DuPont@DuPont, Gerald N VanderwerWAE/DuPontgDuPont Hugh J CanipbelUr/AE/DuPorrt@DuPont, David M Rura!

TRADE SECRET Study Title H-24943: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Laboratory Project ID: DuPont-6544 AR226-3195 DuPont-6544 AUTHOR: Carol Finlay, B.A.